London-based drug giant AstraZeneca (LON:[[ticker:AZN]]) plans to eliminate 113 jobs at its Westborough, MA, plant next month due to generic drug competition for its asthma drug budesonide (Plumicourt), the Boston Globe reports. Our Boston Tech Layoff Tracker has been updated accordingly. AstraZeneca also has a large R&D operation in Waltham, MA, where the company recently completed a major expansion to its facilities, according to the newspaper.
Author: Ryan McBride
Ryan is an award-winning business journalist who contributes to our life sciences and technology coverage. He was previously a staff writer for Mass High Tech, a Boston business and technology newspaper, where he and his colleagues won a national business journalism award from the Society of American Business Editors and Writers in 2008. In recent years, he has made regular TV appearances on New England Cable News.
Prior to MHT, Ryan covered the life sciences, technology, and energy sectors for Providence Business News. He graduated with honors from the University of Rhode Island in 2001 with a bachelor’s degree in communications. When he’s not chasing down news, Ryan enjoys mountain biking and skiing in his home state of Vermont.
View all posts by Ryan McBride
